Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

801 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Inhibitors for Hepatocellular Carcinoma Patients with Extrahepatic Metastases: A Multicenter Retrospective Study.
Liu DY, Li YN, Wu JY, Zeng ZX, Fu YK, Li H, Ou XY, Zhang ZB, Wang SJ, Wu JY, Yan ML. Liu DY, et al. J Hepatocell Carcinoma. 2024 Nov 25;11:2339-2349. doi: 10.2147/JHC.S480958. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39619604 Free PMC article.
Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Li SQ, Wu JY, Wu JY, Xie H, Li JH, Zeng ZX, Fu YK, Liu DY, Li H, Chen WZ, Huang JY, Yan ML. Li SQ, et al. Among authors: liu dy. J Hepatocell Carcinoma. 2023 Oct 11;10:1799-1811. doi: 10.2147/JHC.S428980. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37850080 Free PMC article.
Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study.
Ou X, Wu J, Wu J, Fu Y, Zeng Z, Li S, Li Y, Liu D, Li H, Li B, Zhou J, Zhuang S, Cheng S, Zhang Z, Wang K, Qu S, Yan M. Ou X, et al. Cancer Res Treat. 2024 Oct;56(4):1207-1218. doi: 10.4143/crt.2023.1165. Epub 2024 Apr 30. Cancer Res Treat. 2024. PMID: 38697847 Free PMC article.
Combination Therapy Consisting of Transarterial Chemoembolization, Lenvatinib, and Programmed Cell Death Protein 1 Blockade for Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus: A Case Series Study and Literature Review.
Fu YK, Li YN, Liu DY, Zeng ZX, Wu JY, Wu JY, Wang JX, Li H, Ou XY, Yan ML. Fu YK, et al. Among authors: liu dy. Oncol Res Treat. 2024;47(10):465-473. doi: 10.1159/000540662. Epub 2024 Aug 7. Oncol Res Treat. 2024. PMID: 39111295 Free article. Review.
Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study.
Lin ZT, Wei SM, Wu JY, Zhang ZB, Wang SJ, Zhou JY, Luo MC, Zeng ZX, Ou XY, Fu YK, Li H, Liu DY, Wu JY, Yan ML. Lin ZT, et al. Among authors: liu dy. J Hepatocell Carcinoma. 2024 Sep 24;11:1777-1787. doi: 10.2147/JHC.S477019. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39345939 Free PMC article.
801 results